Association of Molnupiravir and Nirmatrelvir-Ritonavir with preventable mortality, hospital admissions and related avoidable healthcare system cost among high-risk patients with mild to moderate COVID-19

Details 詳細情報について

• CRID

  1360016870444798208

• DOI

  10.1016/j.lanwpc.2022.100602

• ISSN

  26666065

• Web Site

  https://api.elsevier.com/content/article/PII:S2666606522002176?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S2666606522002176?httpAccept=text/plain

• Data Source

  • Crossref